Strong benefits under former CEO, but cuts in 2026 - Recensione dipendente - Dipendente anonimo presso Exact Sciences

4,0
24 mag 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The company was doing well with the old CEO, pretty good benefits such as PTOs, personal holidays, sick days, etc, and health insurance premium.

Svantaggi

The company started to cut benefits in 2026, many people did not get their stock grants. The middle-level management also needs improvement.

Esplora altre recensioni su Exact Sciences

5,0
8 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

culture is great, product is great

Svantaggi

below industry average commission structure and pay

2,0
28 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Quarterly bonuses available based on position and company's current performance. Stock awarded in addition to compensation increase during Q1 of each year

Svantaggi

I got fired 2 hours after I had my quarterly review stating I was doing a great job and making a big difference for the department and the customers we served. My entire department was eliminated on a Monday afternoon, with VP leadership stating a need for outsourcing and cost-cutting measures, the typical "we need to be agile to stay competitive" and "think lean with our spending", the typical corpo speak for "we are cutting positions because AI and we want more money". The very next morning, the company had an earnings call with investors and announced they had their most profitable quarter ever in the company's history. A month later, the company announced it was being bought out by Abbott Laboratories.

Vedi recensioni per: Utile|Valutazione|Data|Tutto